Grant: Catalyst Grant: SPOR Innovative Clinical Trials (iCT)
University of British Columbia
$200,000.00
OPeN seCRET: Optimizing Pragmatic, Novel strategies for iCTs in CeREbral venous Thrombosis
FY 2023-24
Summary
Cerebral venous thrombosis, clotting in the draining veins of the brain, is a rare stroke type that most commonly affects younger adults, usually women. Up to 15% will die or need others to help them with day-to-day activities, and up to 1 in 10 will develop epilepsy. The majority of survivors will have issues with thinking, headache, mood and fatigue that can affect their recovery journey.
We are partnering with patients to learn about better ways to study this rare cause of stroke, including (1) how to include as many people as possible in research who have with CVT from around the world, (2) better ways to include usual health care data in CVT research, and (3) priorities in studying CVT that matter to patients, and the best ways to measure these.
Department
Program
Catalyst Grant: SPOR Innovative Clinical Trials (iCT)
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
487646
Name
Field Thalia S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Catalyst Grant SPOR Innovative Clinical Trials
Projecttitle
OPeN seCRET: Optimizing Pragmatic, Novel strategies for iCTs in CeREbral venous Thrombosis
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$200,000
Cihrequipment2
$0
Programname2
Catalyst Grant: SPOR Innovative Clinical Trials (iCT)
Keyworddelim
Cerebral Venous Thrombosis; Comparative Effectiveness; Patient-Centered Outcomes
Abstract
Cerebral venous thrombosis, clotting in the draining veins of the brain, is a rare stroke type that most commonly affects younger adults, usually women. Up to 15% will die or need others to help them with day-to-day activities, and up to 1 in 10 will develop epilepsy. The majority of survivors will have issues with thinking, headache, mood and fatigue that can affect their recovery journey.
We are partnering with patients to learn about better ways to study this rare cause of stroke, including (1) how to include as many people as possible in research who have with CVT from around the world, (2) better ways to include usual health care data in CVT research, and (3) priorities in studying CVT that matter to patients, and the best ways to measure these.
Competitiondate
202307
Approvedterm2
1 yr 0 mth
Pinamesdelim
Field, Thalia S; Lindsay, Mary Patrice; Roberts, Sharon E; Saposnik, Gustavo
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $200,000~ $0~
